Skip to main content
Equibles
EVGN logo

EVGN · Evogene Ltd.

Track EVGN — free

Use EVGN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.52 -0.03 (-4.95%) At close · Aug 31
Rebalance outlook locked
Market Cap
$8.68M
Shares
15.80M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.55 Open$0.56 Day$0.54–0.56 52W close$0.39–1.46 Avg vol 30d485K Short int232K · 1.5% float · 1.0d Short vol52% Last earningsAug 18, 2026 DataJul 2024–Aug 2026

Raw chart and full-history price indicators begin at the captured split on Jul 25, 2024; bars on opposite sides are not compared.

Up next

Next earnings call
Nov 18, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 14.4 · calm Equity put/call 0.62
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −32%
below
Price vs 50-day avg +4%
above
RSI (14) 48
neutral
MACD trend Negative
52-week position 15%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +17%
trailing
6-month return −28%
trailing
YTD return −50%
this year
Relative strength −41%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Distributing
-13% holders QoQ · +3 funds added
Insider flow Accumulating
Net +$692.8K over 90 days · 0% sells
Short interest Rising
1.47% of float · ▲ +414.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
14 holders — near 3-yr low, contrarian setup
Squeeze score 58
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 79%
annualized · 1-yr
Max drawdown −73%
past year
ATR 10.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Prior guidance period ended · from the Earnings Call filed Sep 30, 2024
Projected cash usage · for 2024 $8M – $10M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−32% Bearish
Price vs 50-day avg
+4% Bullish
RSI (14)
48 Neutral
MACD trend
Negative Bearish
52-week position
15% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Distributing
-13% holders QoQ · +3 funds added
Insider flow Accumulating
Net +$692.8K over 90 days · 0% sells
Short interest Rising
1.47% of float · ▲ +414.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
14 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0 Now $1 · 15% Range high $1
vs 200-day avg -32% vs 50-day avg +4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
EVGN
Evogene Ltd.
this stock
$8.68M -50.0% — — 1.5%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $137.30B +19.5% +46.2% 31.6 1.6%
REGN
Regeneron Pharmaceuticals, Inc.
 $81.77B +2.9% +20.8% 19.7 2.3%
ARGX
Argenx SE
 $64.16B +22.7% — — 1.9%
CSLLY
Csl Ltd
 $59.23B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
14
% held
1.8%
Net QoQ
-248.5K sh
Top holder
HRT FINANCIAL LP
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
232.1K
Days to cover
1.0d
Change
+187.0K sh
View
Short Volume
Short vol %
52%
As of
Aug 31, 2026
Short Total
View
Fails to Deliver
FTD shares
16.0K
Value
$11.2K
As of
Aug 12, 2026
View
Off-Exchange
Off-exchange %
45.5%
Week of
Jul 27, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$692.8K
Buyers / Sellers
2 / 0
Buyers Sellers
View
Filings
SEC Filings
Latest
6-K
Filed
Aug 27, 2026
This year
15
View
Exempt Offerings
Offering
$3.4M
Filed
Feb 19, 2026
View
Earnings & Events
Earnings Calls
Last call
Aug 18, 2026
View

Performance

Raw-price comparisons begin at the captured split on Jul 25, 2024; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
EVGN -1.9% +16.9% -27.7% +16.9% -50.0%
SPY +0.5% +3.0% +13.4% +3.0% +12.8%
vs SPY -2.3% +14.0% -41.1% +14.0% -62.9%
Key facts CIK 1574565 CUSIP M4119S187 13F (30d) 19 filings 16 filers Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)